Qatar Biomedical Research Institute
Qatar Biomedical Research Institute is a non-profit biomedical research institute within Hamad Bin Khalifa University and Qatar Foundation. It operates three centers (Diabetes, Oncology, Neurological Disorders) addressing regional health priorities in Qatar and the wider Arab region.
- Company typePrivate
- Founded2012
- HeadquartersDoha, Qatar
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Qatar Biomedical Research Institute does
Qatar Biomedical Research Institute (QBRI) is a biomedical research institute established in 2012 and operating within Hamad Bin Khalifa University (HBKU) on the Education City campus in Doha, Qatar. QBRI is part of the Qatar Foundation ecosystem and conducts basic and applied research aimed at improving disease prevention, diagnosis, and treatment for health priorities in Qatar and the broader Arab region. The institute is organized around three specialized research centers: the Diabetes Research Center, focused on a condition affecting approximately 20% of Qataris; the Translational Oncology Research Center, developing diagnostic and treatment tools with emphasis on breast cancer; and the Neurological Disorders Research Center, focused on autism spectrum disorder and related conditions of rising regional prevalence. QBRI also runs a Summer Research Program providing intensive biomedical research training to undergraduate students.
QBRI's operating model is that of a non-profit university research institution rather than a commercial enterprise. It is funded through institutional research grants from Qatar Foundation and aligned government entities, and it has no disclosed commercial pricing or products. Its distribution channels are academic: peer-reviewed publications, conference presentations, collaborations with international research institutions, and policy advisory work with the Qatar Ministry of Public Health. Its named external collaborators include Hamad Medical Corporation for clinical research, the Ministry of Public Health for national surveys on developmental disabilities, and a network of international research partners. A Scientific Advisory Committee of elite external scientists provides governance over research quality and direction.
The institute serves 51-100 employees including principal investigators, researchers, and summer program participants, and contributes to HBKU's broader research output of 210,000+ citations and 8,300+ publications. QBRI's customer base is essentially governmental and quasi-governmental: Qatar Foundation, the Ministry of Public Health, and Hamad Medical Corporation represent the principal demand for its research outputs, with secondary engagement from undergraduate students and regional healthcare institutions. There is no evidence of commercial revenue generation, equity funding, M&A activity, or productized offerings in the input data.
Qatar Biomedical Research Institute firmographics
Firmographics- Name
- Qatar Biomedical Research Institute
- Legal name
- Qatar Biomedical Research Institute
- Website
- https://hbku.edu.qa
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Qatar Biomedical Research Institute is a non-profit biomedical research institute within Hamad Bin Khalifa University and Qatar Foundation. It operates three centers (Diabetes, Oncology, Neurological Disorders) addressing regional health priorities in Qatar and the wider Arab region.
- Ownership category
- akta.pro rank
Qatar Biomedical Research Institute industry classification
Industry- Product category
- Biomedical Research Services
- NAICS
- Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- National Public Health Reference Laboratories (HLAJAIAA)
- akta.pro secondary industries
- Clinical Research & Trial Central Laboratories (HLAFAMAL), Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms (HLACAOAM)
Keywords
Where Qatar Biomedical Research Institute is headquartered
LocationHeadquarters
- HQ city
- Doha
- HQ country
- Qatar
- HQ region
- Middle East
Offices1 record
Markets served
Qatar Biomedical Research Institute business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure
Revenue model
- Institutional Research Funding: As a research institute under Hamad Bin Khalifa University, QBRI operates as a non-profit educational research institution supported by institutional funding from Qatar Foundation and government research grants. The institute conducts research to improve healthcare in Qatar through new discoveries in prevention, diagnosis, and treatment of diseases.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Qatar Biomedical Research Institute product offering
Product offeringCore offering
QBRI is a multidisciplinary biomedical research institute operating three specialized centers—the Diabetes Research Center, the Translational Oncology Research Center, and the Neurological Disorders Research Center—focused on developing prevention, diagnosis, and treatment strategies for diseases with high prevalence in Qatar and the broader region. The institute conducts basic and applied research, translates discoveries into clinical applications, and runs the Summer Research Program to train undergraduate students.
Product overview
Qatar Biomedical Research Institute (QBRI) is a research institute within Hamad Bin Khalifa University operating as a multidisciplinary biomedical research facility. QBRI comprises three specialized research centers: the Diabetes Research Center, focusing on diabetes prevention, diagnosis, and treatment strategies; the Translational Oncology Research Center, developing diagnostic tools and cancer treatments with emphasis on breast cancer; and the Neurological Disorders Research Center, exploring autism and other neurological conditions prevalent in the region. The institute also offers a Summer Research Program for undergraduate students. QBRI's mission centers on advancing healthcare through cutting-edge research and translating scientific discoveries into clinical applications, particularly for diseases affecting Qatar and the MENA region.
Differentiator
Problem solved
Functional benefit
Products and services
- QBRI Biomedical Research Programs A multidisciplinary biomedical research offering dedicated to improving healthcare in Qatar and the region through discoveries in the prevention, diagnosis, and treatment of diseases, serving Qatar's national healthcare priorities and academic collaborators.
- Diabetes Research Center A specialized research center focused on applying research findings to develop strategies for the prevention, diagnosis, and treatment of diabetes and related metabolic disorders in Qatar and beyond.
- Translational Oncology Research Center A specialized research center developing diagnostic tools and treatment strategies to improve cancer patient care, with particular focus on breast cancer—the most common cancer among women globally—and cancers prevalent in Qatar and the region.
- Neurological Disorders Research Center A specialized research center focused on exploring neurological disorders with increasing prevalence in Qatar and the broader region, particularly autism spectrum disorder.
- QBRI Summer Research Program An intensive research opportunity for outstanding undergraduate students providing hands-on research experience in various medical science fields, offered as part of QBRI's training and capacity-building mission.
Quantifiable outcome
- Contributing to HBKU's 210,000+ citations and 8,300+ publications across the university
- +1 more outcomes
Companies that use Qatar Biomedical Research Institute
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Qatar Biomedical Research Institute technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Qatar Biomedical Research Institute partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and major.
- Hamad Bin Khalifa University (Parent Institution)coreQBRI is a member institute of Hamad Bin Khalifa University, operating within the university's Education City campus. The institute benefits from HBKU's academic infrastructure, interdisciplinary research environment, and administrative support.
- Qatar FoundationcoreAs part of HBKU which is a member of Qatar Foundation, QBRI benefits from the foundation's ecosystem of education and research institutions, including access to shared facilities and collaborative opportunities across Education City.
- Healthcare Institutions in QatarmajorCollaborations with Hamad Medical Corporation and other healthcare providers for clinical research initiatives, including the national survey on developmental disabilities diagnostics and interventions conducted with Ministry of Public Health.
- International Research InstitutionsmajorPartnerships with prestigious national and international institutions for long-term collaborations, knowledge sharing, and joint research programs in biomedical sciences.
- Ministry of Public Health (Qatar)majorCollaborative initiatives including national surveys on developmental disabilities, contributing to evidence-based healthcare policy development.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Qatar Biomedical Research Institute competitors and assessment
Company assessmentBroad incumbents
- Broad Institute of MIT and Harvard: Major U.S. biomedical and genomic research institute operating at vastly larger scale; comparable to QBRI in disease research focus areas (cancer, diabetes/metabolic disease) but with substantially broader capabilities.
- Francis Crick Institute: One of Europe's largest biomedical research institutes covering cancer, neuroscience, and immunology, serving as an analogous flagship national biomedical research center to QBRI but at substantially larger scale.
- Karolinska Institutet: Sweden's premier medical university with extensive biomedical research programs across cancer, neuroscience, and metabolic diseases — representing a much larger, globally recognized peer in the same research category.
- Pasteur Institute: Global biomedical research network with deep expertise in infectious disease and public health, representing a much larger established player in the same biomedical research category as QBRI.
- RIKEN: Japan's flagship national research institute covering life sciences, biomedical, and translational research — directly analogous to QBRI as a government-backed multidisciplinary biomedical research organization, though at far greater scale.
Direct peers
- Wellcome Sanger Institute: UK-based genomics and biomedical research institute conducting large-scale research in cancer, infectious disease, and population genetics — closely aligned to QBRI's translational research scope.
- Sidra Medicine: Also based in Qatar's Education City, Sidra Medicine combines biomedical research with clinical care across women's and children's health, making it the most direct peer in scope and geography to QBRI.
- Weill Cornell Medicine-Qatar: Operates as Qatar's principal medical research and education institution with strong U.S. medical school affiliation, overlapping with QBRI's biomedical research mission and sharing the same Education City ecosystem.
- King Abdullah International Medical Research Center (KAIMRC): Saudi Arabia's national biomedical research arm under the Ministry of National Guard, conducting translational research across genomics, oncology, and metabolic diseases — directly comparable to QBRI's mission scope.
- King Faisal Specialist Hospital and Research Centre: Saudi Arabia's flagship research hospital combining clinical care with biomedical research programs in cancer, genetics, and translational medicine — a comparable GCC biomedical research model to QBRI.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Qatar Biomedical Research Institute social profiles
Digital presenceQatar Biomedical Research Institute financial estimates
Financial estimateRevenue estimate
Valuation estimate
Qatar Biomedical Research Institute leadership team
Management profileNumber of profiles
Profiles1 record
Qatar Biomedical Research Institute funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Qatar Biomedical Research Institute M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Qatar Biomedical Research Institute
What does Qatar Biomedical Research Institute do?
QBRI is a multidisciplinary biomedical research institute operating three specialized centers—the Diabetes Research Center, the Translational Oncology Research Center, and the Neurological Disorders Research Center—focused on developing prevention, diagnosis, and treatment strategies for diseases with high prevalence in Qatar and the broader region. The institute conducts basic and applied research, translates discoveries into clinical applications, and runs the Summer Research Program to train undergraduate students.
Is Qatar Biomedical Research Institute a public or private company?
Qatar Biomedical Research Institute is a private company. It is classified as state government owned and is currently operating.
When was Qatar Biomedical Research Institute founded?
Qatar Biomedical Research Institute was founded in 2012. It employs 51 to 100 people.
Where is Qatar Biomedical Research Institute based?
Qatar Biomedical Research Institute is headquartered in Doha, Qatar, in the Middle East region.
How does Qatar Biomedical Research Institute make money?
One revenue line is on record: institutional Research Funding.
Who are Qatar Biomedical Research Institute's main competitors?
Broad incumbents on record are Broad Institute of MIT and Harvard, Francis Crick Institute, Karolinska Institutet, Pasteur Institute and RIKEN. Direct peers are Wellcome Sanger Institute, Sidra Medicine, Weill Cornell Medicine-Qatar, King Abdullah International Medical Research Center (KAIMRC) and King Faisal Specialist Hospital and Research Centre.
Does Qatar Biomedical Research Institute have an API?
No public API is recorded for Qatar Biomedical Research Institute.
What industry is Qatar Biomedical Research Institute in?
Qatar Biomedical Research Institute's product category is Biomedical Research Services. Its primary akta.pro industry code is HLAJAIAA, National Public Health Reference Laboratories, with a secondary code of HLAFAMAL, Clinical Research & Trial Central Laboratories. Its NAICS code is 5417 and its SIC code is 8731.